These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30980862)

  • 41. Non-HLA Antibodies May Accelerate Immune Responses After Intestinal and Multivisceral Transplantation.
    Gerlach UA; Lachmann N; Ranucci G; Sawitzki B; Schoenemann C; Pratschke J; Dragun D; Pascher A
    Transplantation; 2017 Jan; 101(1):141-149. PubMed ID: 27495766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Presence of Anti-Angiotensin II Type-1 Receptor Antibodies Adversely Affect Kidney Graft Outcomes.
    Zhang J; Wang M; Liang J; Zhang M; Liu XH; Ma L
    Int J Environ Res Public Health; 2017 May; 14(5):. PubMed ID: 28486415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical implications of angiotensin II type 1 receptor antibodies in antibody-mediated rejection without detectable donor-specific HLA antibodies after renal transplantation.
    Lee J; Park Y; Kim BS; Lee JG; Kim HJ; Kim YS; Huh KH
    Transplant Proc; 2015 Apr; 47(3):649-52. PubMed ID: 25891704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal ischemia and transplantation predispose to vascular constriction mediated by angiotensin II type 1 receptor-activating antibodies.
    Lukitsch I; Kehr J; Chaykovska L; Wallukat G; Nieminen-Kelhä M; Batuman V; Dragun D; Gollasch M
    Transplantation; 2012 Jul; 94(1):8-13. PubMed ID: 22691955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. AT1R Activating Autoantibodies in Hematopoietic Stem Cell Transplantation.
    Bradford KL; Pearl M; Kohn DB; Weng P; Yadin O; Bowles V; De Oliveira SN; Moore TB
    Biol Blood Marrow Transplant; 2020 Nov; 26(11):2061-2067. PubMed ID: 32736008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin II Type 1 Receptor Antibody-mediated Rejection Following Orthotopic Heart Transplant: A Single-center Experience.
    Moreno JD; Verma AK; Kopecky BJ; Dehner C; Kostelecky N; Vader JM; Lin CY; Schilling JD
    Transplantation; 2022 Feb; 106(2):373-380. PubMed ID: 33988339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-HLA AT1R antibodies are highly prevalent after pediatric intestinal transplantation.
    Chan AP; Guerra MR; Rossetti M; Hickey MJ; Venick RS; Marcus EA; McDiarmid SV; Farmer DG; Reed EF; Wozniak LJ
    Pediatr Transplant; 2021 May; 25(3):e13987. PubMed ID: 33590644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pre-transplant angiotensin receptor II type 1 antibodies and risk of post-transplant focal segmental glomerulosclerosis recurrence.
    Mujtaba MA; Sharfuddin AA; Book BL; Goggins WC; Khalil AA; Mishler DP; Fridell JA; Yaqub MS; Taber TE
    Clin Transplant; 2015 Jul; 29(7):606-11. PubMed ID: 25973696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessing the potential of angiotensin II type 1 receptor and donor specific anti-endothelial cell antibodies to predict long-term kidney graft outcome.
    Pinelli DF; Friedewald JJ; Haarberg KMK; Radhakrishnan SL; Zitzner JR; Hanshew WE; Tambur AR
    Hum Immunol; 2017; 78(5-6):421-427. PubMed ID: 28372986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibody-Mediated Rejection in Kidney Transplantation Without Evidence of Anti-HLA Antibodies?
    Irure J; López-Hoyos M; Rodrigo E; Gómez-Román J; Ruiz JC; Arias M; San Segundo D
    Transplant Proc; 2016 Nov; 48(9):2888-2890. PubMed ID: 27932099
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of Antibody against Angiotensin II Type 1 Receptor (AT1R) Among Thai Kidney Transplant Patients.
    Viboon S; Townamchai N; Phiancharoen S; Kupatawintu P; Dhitivat V; Nathalang O
    Transplant Proc; 2018 Jun; 50(5):1310-1315. PubMed ID: 29880351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
    Cuevas E; Arreola-Guerra JM; Hernández-Méndez EA; Salcedo I; Castelán N; Uribe-Uribe NO; Vilatobá M; Contreras-Saldívar AG; Sánchez-Cedillo AI; Ramírez JB; de Rungs D; Granados J; Morales-Buenrostro LE; Alberú J
    Nephrol Dial Transplant; 2016 Oct; 31(10):1738-45. PubMed ID: 27220757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensin II type 1 receptor antibody precipitating acute vascular rejection in kidney transplantation.
    Jobert A; Rao N; Deayton S; Bennett GD; Brealey J; Nolan J; Carroll RP; Dragun D; Coates PT
    Nephrology (Carlton); 2015 Mar; 20 Suppl 1():10-2. PubMed ID: 25807851
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin II Type 1 Receptor Mechanoactivation Involves RGS5 (Regulator of G Protein Signaling 5) in Skeletal Muscle Arteries: Impaired Trafficking of RGS5 in Hypertension.
    Hong K; Li M; Nourian Z; Meininger GA; Hill MA
    Hypertension; 2017 Dec; 70(6):1264-1272. PubMed ID: 29061726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-angiotensin II type 1 receptor autoantibodies (AT
    İlgen U; Yayla ME; Düzgün N
    Rheumatol Int; 2017 Apr; 37(4):593-598. PubMed ID: 28004166
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of anti-AT1R reactivity in ELISA post-adsorption - False reactivity or interference in the assay?
    Xu Q; Johnson KP; Hardiman M; Helmick D; Zeevi A
    Hum Immunol; 2023 Apr; 84(4):286-289. PubMed ID: 36764862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Angiotensin II type 1 receptor antibodies and native kidney function in pediatric liver and intestinal transplant recipients.
    Stern R; Chen L; Chan AP; Wozniak LJ; Pearl M
    Pediatr Nephrol; 2023 Dec; 38(12):4175-4185. PubMed ID: 37432534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiotensin II Type 1 Receptor Binding Molecule ATRAP as a Possible Modulator of Renal Sodium Handling and Blood Pressure in Pathophysiology.
    Tamura K; Wakui H; Azushima K; Uneda K; Haku S; Kobayashi R; Ohki K; Haruhara K; Kinguchi S; Matsuda M; Yamashita A; Umemura S
    Curr Med Chem; 2015; 22(28):3210-6. PubMed ID: 26295465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene polymorphisms of the renin-angiotensin-aldosterone system and angiotensin II type 1-receptor activating antibodies in renal rejection.
    Zhang G; Wang H; Wang F; Yu L; Yang X; Meng J; Qin W; Wu G; Li J; Yang A; Zhou Y; Zhang R
    Tohoku J Exp Med; 2007 Nov; 213(3):203-14. PubMed ID: 17984617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Humoral immunity in hand transplantation: anti-HLA and non-HLA response.
    Banasik M; Jabłecki J; Boratyńska M; Kamińska D; Kościelska-Kasprzak K; Bartoszek D; Chełmoński A; Hałoń A; Baran W; Klinger M
    Hum Immunol; 2014 Aug; 75(8):859-62. PubMed ID: 24952209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.